§
PatentCue
Patent Intelligence
Join Waitlist Sign In
← Back to Patent Explorer
US6582394B1 Expired / Lapsed US ⏱️ 0.0 years remaining

Stent and catheter assembly and method for treating bifurcated vessels

Assignee: Abbott Cardiovascular Systems Inc
•
Filing: 2000-11-14
•
Granted: 2003-06-24
•
Expires: 2020-11-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An apparatus and method is provided for stenting bifurcated vessels. A main-vessel stent and delivery system is provided for implanting a stent in the main vessel of a bifurcated vessel, wherein the main-vessel stent has an aperture bordered by closed stent cells that aligns with the opening to a side-branch vessel to permit substantially unobstructed blood flow between the main vessel and the side-branch vessel. The delivery system includes a catheter assembly having distal and proximal balloons separated by a positioning guide wire exit port located at the distal end of the catheter. The catheter assembly is advanced over a pair of guide wires for delivering, appropriately orienting, and implanting the main-vessel stent.

Inventors

  • 👤 Paul Reiss
  • 👤 Mary Dennehy

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 05:56
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/82; A61F2/856; A61F2/86; A61F2/90; A61F2/91; A61F2/915; A61F2/95; A61F2/954; A61F2/958; A61F2002/91508; A61F2002/91516; A61F2002/91525; A61F2002/91533; A61F2002/9155; A61F2002/91575; A61F2250/00; A61F2250/0014

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 141 words
A main-vessel stent for implanting in a main vessel adjacent a bifurcation, comprising: a cylindrical member having a distal end and a proximal end and an outer wall surface therebetween; and a plurality of closed stent cells, at least some of the closed cells having a first perimeter and at least some of the closed cells having a second perimeter; an aperture on the outer wall surface, the aperture having a third perimeter formed entirely of the closed stent cells, the third perimeter being different than either of the first perimeter and the second perimeter, the aperture being sized and positioned on the outer wall surface so that when the stent is implanted in a main vessel, the third aperture is aligned with a side-branch vessel thereby allowing substantially unrestricted blood flow from the main vessel through to the side-branch vessel.
Claim 2
Dependent Claim 141 words
A main-vessel stent for implanting in a main vessel adjacent a bifurcation, comprising: a cylindrical member having a distal end and a proximal end and an outer wall surface therebetween; and a plurality of closed stent cells, at least some of the closed cells having a first perimeter and at least some of the closed cells having a second perimeter; an aperture on the outer wall surface, the aperture having a third perimeter formed entirely of the closed stent cells, the third perimeter being different than either of the first perimeter and the second perimeter, the aperture being sized and positioned on the outer wall surface so that when the stent is implanted in a main vessel, the third aperture is aligned with a side-branch vessel thereby allowing substantially unrestricted blood flow from the main vessel through to the side-branch vessel.
Claim 3
Dependent Claim 43 words
The main-vessel stent of claim 1 , wherein the stent is expandable from a first smaller diameter for delivery in a body lumen to a second expanded diameter by plastically deforming the stent beyond the elastic limits of the material forming the stent.
Claim 4
Dependent Claim 41 words
The main-vessel stent of claim 1 , wherein the stent is formed from a self-expanding material so that the stent expands from a first smaller diameter for delivery through a body lumen to a second implanted diameter in the body lumen.
Claim 5
Dependent Claim 43 words
The main-vessel stent of claim 1 , wherein the cylindrical member further comprises: a distal region adjacent the distal end, a proximal region adjacent the proximal end and a central region located therebetween; and wherein the aperture is formed in the central region.
Claim 6
Dependent Claim 35 words
The main-vessel stent of claim 4 , wherein the stent cells of the distal and proximal regions have a first cell size and the stent cells of the central region have a second cell size.
Claim 7
Dependent Claim 19 words
The main-vessel stent of claim 5 , wherein the second cell size is less than the first cell size.
Claim 8
Dependent Claim 23 words
The main-vessel stent of claim 6 , wherein the second cell size is about one half the size of the first cell size.

References Cited (Backward Citations)

US2845959A Cited
US2990605A Cited
US2978787A Cited
US3096560A Cited
US3142067A Cited
US3029819A Cited
US3397699A Cited
US3945052A Cited
US3908662A Cited
US4061134A Cited
US4108161A Cited
US4047252A Cited
US4041931A Cited
US4140126A Cited
US4193137A Cited
US4202349A Cited
US4214587A Cited
US4517687A Cited
US4560374A Cited
US4787899A Cited
US6030413A Cited
US5108424A Cited
US5197977A Cited
US4562596A Cited
US4617932A Cited
SU1217402A1 Cited
SU1318235A1 Cited
US4728328A Cited
US4577631A Cited
US4732152A Cited
US4652263A Cited
US4693249A Cited
US4878906A Cited
US5749888A Cited
SU1482714A2 Cited
US4793348A Cited
SU1389778A2 Cited
US5104399A Cited
US5047050A Cited
SU1457921A1 Cited
US4795465A Cited
US4872874A Cited
US4795458A Cited
US4892539A Cited
US4830003A Cited
US5226913A Cited
US5127919A Cited
US4969896A Cited
US5178634A Cited
US4994071A Cited
US5026377A Cited
US5578072A Cited
US5683452A Cited
US5578071A Cited
US5591229A Cited
US5571171A Cited
US5571173A Cited
EP0461791B1 Cited
US5360443A Cited
US5693087A Cited
US5522880A Cited
US5156619A Cited
US5064435A Cited
EP0466518B1 Cited
US5178630A Cited
US5413581A Cited
US5222971A Cited
FR2673843B1 Cited
US5628783A Cited
US5197978B1 Cited
US5197978A Cited
US5743875A Cited
US5571167A Cited
US5304220A Cited
US5456712A Cited
US5197976A Cited
US5443498A Cited
US5234457A Cited
US5693084A Cited
US5562726A Cited
US5603721A Cited
US5683453A Cited
US5316023A Cited
US5571170A Cited
US6039754A Cited
US5639278A Cited
US5632772A Cited
US5871536A Cited
US5693088A Cited
US5443497A Cited
US5607444A Cited
US5562724A Cited
US5916234A Cited
US5800508A Cited
US5776180A Cited
US5916263A Cited
US5683450A Cited
US6051020A Cited
US5718724A Cited
US5938696A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2006-06-23 2006-12-23 2007-06-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2010-06-23 2010-12-23 2011-06-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2014-06-23 2014-12-23 2015-06-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag